| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |